Angie Schwab is a clinical trials expert, a four-time innovator in clinical trial software, and a self-proclaimed clinical research futurist. With 20 years of industry experience and leadership in over 200 clinical trials, she combines deep clinical insight with transformative technology. Angie is passionate about leveraging smart AI and automation to revolutionize the design and execution of clinical trials.
She is the creator of Trialynx, an AI-powered platform that acts as a central hub for study development and documentation, enhancing efficiency, consistency, and ushering in a new era of intelligent clinical research. Trialynx accelerates clinical trial development by using AI and automation to produce complete, compliant study documentation from a simple synopsis—delivering results in hours rather than months.
The platform offers flexible delivery models, including both full-service support and platform licensing, to accommodate diverse research needs.
